Prophylactic HPV vaccines: prospects for eliminating ano-genital cancer
Open Access
- 20 March 2007
- journal article
- review article
- Published by Springer Science and Business Media LLC in British Journal of Cancer
- Vol. 96 (9), 1320-1323
- https://doi.org/10.1038/sj.bjc.6603695
Abstract
Virtually all cases of cervical cancer and its precursor intra-epithelial lesions are a result of infection with one or other of a subset of genital human papillomaviruses (HPVs), suggesting that prevention of HPV infection by prophylactic vaccination would be a highly effective anticancer strategy. Two HPV L1 virus-like particle vaccines have been developed, a quadrivalent HPV16/18/6/11 product and a bivalent HPV16/18 product; both have been shown to be highly immunogenic with a good safety profile and 100% efficacy against HPV16/18-related high-grade cervical intra-epithelial neoplasia (CIN2/3), implying that they will be effective at preventing HPV16/18-related cervical cancer.Keywords
This publication has 25 references indexed in Scilit:
- High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-upBritish Journal of Cancer, 2006
- Comparison of the Immunogenicity and Reactogenicity of a Prophylactic Quadrivalent Human Papillomavirus (Types 6, 11, 16, and 18) L1 Virus-Like Particle Vaccine in Male and Female Adolescents and Young Adult WomenPublished by American Academy of Pediatrics (AAP) ,2006
- Chapter 3: HPV type-distribution in women with and without cervical neoplastic diseasesVaccine, 2006
- Chapter 2: The burden of HPV-related cancersVaccine, 2006
- The epidemiology of genital human papillomavirus infectionVaccine, 2006
- Efficacy of Human Papillomavirus-16 Vaccine to Prevent Cervical Intraepithelial NeoplasiaObstetrics & Gynecology, 2006
- Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysisBritish Journal of Cancer, 2003
- Comparison of Human Papillomavirus Types 16, 18, and 6 Capsid Antibody Responses Following Incident InfectionThe Journal of Infectious Diseases, 2000
- Vaccination with yeast-expressed cottontail rabbit papillomavirus (CRPV) virus-like particles protects rabbits from CRPV-induced papilloma formationVaccine, 1995
- IMMUNIZATION OF RABBITS TO INFECTIOUS PAPILLOMATOSISThe Journal of Experimental Medicine, 1937